SWARTZ ROBIN (Chief Operating Officer) sold 1.1% of their position (1.36K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2024ACC: 0001104659-24-043107
Officer· Chief Operating Officer
Since Feb 2022
-1.36K
Net shares
Net seller
$13.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.36K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.36K
Price / share
$9.88
Trade value
$13.41K
% of position
1.1%
4/2/2024
118.36K→117K
Total
Net shares
−1.36K
Net value
-$13.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2024 | S · Sale | −1.36K | $9.88 | $13.41K | 1.1% | 118.36K | 117K |
| Total | −1.36K | -$13.41K | ||||||
Derivative Transactions0
No derivative transactions reported